The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Open accessAbstract
For several decades scientists have speculated that the key to understanding age-related neurodegenerative disorders may be found in the unusual biology of the prion diseases. Recently, owing largely to the advent of new disease models, this hypothesis has gained experimental momentum. In a remarkable variety of diseases, specific proteins have been found to misfold and aggregate into seeds that structurally corrupt like proteins, causing them to aggregate and form pathogenic assemblies ranging from small oligomers to large masses of amyloid. Proteinaceous seeds can therefore serve as self-propagating agents for the instigation and progression of disease. Alzheimer's disease and other cerebral proteopathies seem to arise from the de novo misfolding and sustained corruption of endogenous proteins, whereas prion diseases can also be infectious in origin. However, the outcome in all cases is the functional compromise of the nervous system, because the aggregated proteins gain a toxic function and/or lose their normal function. As a unifying pathogenic principle, the prion paradigm suggests broadly relevant therapeutic directions for a large class of currently intractable diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The recent discovery that specific misfolded and aggregated proteins can propagate and spread in a prion-like fashion has sparked considerable interest (67).”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In Parkinson’s disease and Lewy body disease, α-synuclein aggregates initially spread through the brainstem and olfactory bulb followed by limbic structures, and only thence to the neocortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“In each of these cases, the aggregates initially deposit at the ventral base of the forebrain and midbrain, and then extend rostrally and dorsally to the cortex.”
From Glymphatic failure as a final common pathway to dementia (2020) · cites this paper as [67]
In the citing paper
“While still a contentious topic [46], there is now substantial evidence that also supports the idea that propagation of pathological tau species occurs between cells [47–50].”
From Glial contributions to neurodegeneration in tauopathies (2017) · cites this paper as [50]
In the citing paper
“As aforementioned, the neuropathological lesions of not only AD but also PD/DLB and amyotrophic lateral sclerosis (ALS) are known to spread through the brain in a rather specific pattern, which also serves as a basis for the neuropathological staging of disease severity [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“Importantly, the spatiotemporal spread of αSyn lesions in PD/DLB is nearly inverted to the spread of Aβ and tau pathology as observed in AD [203].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [203]
In the citing paper
“pathological neurofibrillary Tau aggregates show a pattern of accumulation that starts in the entorhinal cortex and spreads through connected pathways to cortical areas (Jucker and Walker, 2013)”
From Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease (2020) · cites this paper as Jucker and Walker, 2013
In the citing paper
“It has been suggested that alpha-synuclein could act like a prion protein during PD pathogenesis.In this theory pathologic, misfolded alpha-synuclein is an 'infectious' protein spreading pathology by forming a template that seeds misfolding for nearby alpha-synuclein protein, turning the previously healthy protein into a pathogenic protein (Jucker and Walker, 2013;Visanji et al., 2013).”
From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Jucker and Walker, 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,497
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,000
DNP-Assisted NMR Investigation of Proteins at Endogenous Levels in Cellular Milieu
Costello, W. N., Xiao, Y., & Frederick, K. K. (2018) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.08.023 · Cited by 17
Protein aggregate formation permits millennium-old brain preservation
Petzold, A., Lu, C., Groves, M., Gobom, J., Zetterberg, H., Shaw, G., & O’Connor, S. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2019.0775 · Cited by 17
Sze, C., Kuo, Y., Hsu, L., Fu, T. F., Chiang, M. F., Chang, J.-Y., & Chang, N. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.251 · Cited by 18
The Priority position paper: Protecting Europe's food chain from prions
Requena, J. R., Kristensson, K., Korth, C., Zurzolo, C., Simmons, M. M., Aguilar‐Calvo, P., Aguzzi, A., Andréoletti, O., Benestad, S. L., Böhm, R., et al. (2016) · Prion · doi:10.1080/19336896.2016.1175801 · Cited by 17
Evidence for iatrogenic transmission of Alzheimer’s disease
Jucker, M., & Walker, L. C. (2024) · Nature Medicine · doi:10.1038/s41591-023-02768-9 · Cited by 17
Self-citationCarbon dots for drug delivery: Insights into their potential in nanopharmacology
Iannazzo, D., Celesti, C., Cardo, L. F., Prato, M., & Bitto, A. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100107 · Cited by 16
Tackling prion diseases: a review of the patent landscape
Zattoni, M., & Legname, G. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1945033 · Cited by 17
Fayard, A., Fenyi, A., Lavisse, S., Doveró, S., Bousset, L., Bellande, T., Lecourtois, S., Jouy, C., Guillermier, M., Jan, C., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106086 · Cited by 17
MRI-Based Mapping of Cerebral Propagation in Amyotrophic Lateral Sclerosis
Müller, H., & Kassubek, J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00655 · Cited by 16
The primary neuronal cells are more resistant than PC12 cells to α-synuclein toxic aggregates
Heravi, M., Dargahi, L., Parsafar, S., Marvian, A. T., Aliakbari, F., & Morshedi, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.055 · Cited by 16
Xu, Y., & Xiao, L. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00302f · Cited by 16
Lin, X., Watanabe, K., Kuragano, M., Kurotaki, Y., Nakanishi, U., & Tokuraku, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176031 · Cited by 16
Trumbore, C. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201025 · Cited by 17
Juengling, F. D., Wuest, F. R., Kalra, S., Agosta, F., Schirrmacher, R., Thiel, A., Thaiss, W. M., Müller, H., & Kassubek, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.890425 · Cited by 16
Interactions between heme and tau-derived R1 peptides: binding and oxidative reactivity
Pirota, V., Monzani, E., Dell’Acqua, S., & Casella, L. (2016) · Dalton Transactions · doi:10.1039/c6dt02183b · Cited by 16
Trumbore, C. N. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171003 · Cited by 16
Dadgar‐Kiani, E., Bieri, G., Melki, R., Gitler, A. D., & Lee, J. H. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111631 · Cited by 15
Giacomucci, G., Mazzeo, S., Ingannato, A., Crucitti, C., Bagnoli, S., Padiglioni, S., Romano, L., Galdo, G., Emiliani, F., Frigerio, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-61655-6 · Cited by 15
RNA‐Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins
Rabbani, S. A., El‐Tanani, M., Sharma, S., El‐Tanani, Y., Kumar, R., Saini, M., Yadav, M., Khan, M. A., & Parvez, S. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70110 · Cited by 15
Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly
Seither, K. M., McMahon, H. A., Singh, N., Wang, H. H., Cushman-Nick, M., Montalvo, G. L., DeGrado, W. F., & Shorter, J. (2014) · Biochemical Journal · doi:10.1042/bj20131609 · Cited by 15
Catastrophic cliffs: a partial suggestion for selective vulnerability in neurodegenerative diseases
Hardy, J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20150287 · Cited by 15
Spreading of Pathology in Alzheimer’s Disease
Lv, Z., Tan, C., Yu, J., & Tan, L. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9765-2 · Cited by 15
Allison, W. T., DuVal, M. G., Nguyen-Phuoc, K., & Leighton, P. L. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102223 · Cited by 17
Differences in topological progression profile among neurodegenerative diseases from imaging data
Garbarino, S., Lorenzi, M., Oxtoby, N. P., Vinke, E. J., Marinescu, R. V., Eshaghi, A., Ikram, M. A., Niessen, W. J., Ciccarelli, O., Barkhof, F., et al. (2019) · eLife · doi:10.7554/elife.49298 · Cited by 16
Ikeda, K., Suzuki, S., Shigemitsu, Y., Tenno, T., Goda, N., Oshima, A., & Hiroaki, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-69129-1 · Cited by 15
C. elegans Models to Study the Propagation of Prions and Prion-Like Proteins
Sandhof, C. A., Hoppe, S. O., Tittelmeier, J., & Nussbaum-Krammer, C. I. (2020) · Biomolecules · doi:10.3390/biom10081188 · Cited by 15
Son, M., & Wickner, R. B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205500119 · Cited by 15
Hester, K., Kirrane, E. F., Anderson, T., Kulikowski, N., Simmons, J. E., & Lehmann, D. M. (2022) · Environment International · doi:10.1016/j.envint.2022.107528 · Cited by 15
Flores‐Cuadrado, A., Saiz‐Sánchez, D., Mohedano‐Moriano, A., Martı́nez-Marcos, A., & Úbeda‐Bañón, I. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0713-7 · Cited by 15
Entropic Bristles Tune the Seeding Efficiency of Prion-Nucleating Fragments
Michiels, E., Liu, S., Gallardo, R. U., Louros, N. N., Mathelié‐Guinlet, M., Dufrêne, Y. F., Schymkowitz, J. W. H., Vorberg, I. M., & Rousseau, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.098 · Cited by 15
Bendifallah, M., Redeker, V., Monsellier, É., Bousset, L., Bellande, T., & Melki, R. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.091 · Cited by 15
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15
ApoE-calypse tau: ApoE–tau synergy in Alzheimer’s disease
Lennol, M. P., Bordier, C., Kamelher, L., Ulrich, J. D., Holtzman, D. M., & Gratuze, M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250965 · Cited by 14
Structural effects of the highly protective V127 polymorphism on human prion protein
Hosszu, L. L. P., Conners, R., Sangar, D., Batchelor, M., Sawyer, E. B., Fisher, S. J., Cliff, M. J., Hounslow, A. M., McAuley, K. E., Brady, R. L., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01126-6 · Cited by 15
Current Psychological Approaches in Neurodegenerative Diseases
Kormas, P., & Moutzouri, A. (2022) · Springer eBooks · doi:10.1007/978-3-319-75479-6_10-1 · Cited by 14
Mate, V., Smolek, T., Kazmerova, Z., Jadhav, S., Brezováková, V., Jurkanin, B., Uhrinova, I., Basheer, N., Žilka, N., Katina, S., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.935973 · Cited by 15
Tullo, S., de Miranda, A. S., del Cid‐Pellitero, E., Lim, M. P., Gallino, D., Attaran, A., Patel, R., Novikov, V., Park, M., Beraldo, F. H., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15967 · Cited by 17
Seol, S.-I., Davaanyam, D., Oh, S.-A., Lee, E. H., Han, P., Kim, S., & Lee, J.-K. (2024) · Cells · doi:10.3390/cells13020189 · Cited by 15
Do Bacterial Outer Membrane Vesicles Contribute to Chronic Inflammation in Parkinson’s Disease?
Koukoulis, T. F., Beauchamp, L. C., Kaparakis‐Liaskos, M., McQuade, R. M., Purnianto, A., Finkelstein, D. I., Barnham, K. J., & Vella, L. J. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230315 · Cited by 14
Braun, M., Simon, M. J., Jang, J., Sanderson, K., Swierz, J., Sevao, M., Pincus, A. B., Schaser, A. J., Elliott, J. E., Lim, M. M., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag327 · Cited by 14
Orientation of aromatic residues in amyloid cores: Structural insights into prion fiber diversity
Reymer, A., Frederick, K. K., Rocha, S., Beke‐Somfai, T., Kitts, C. C., Lindquist, S. L., & Nordén, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415663111 · Cited by 14
Li, M., Xi, N., Wang, Y., & Liu, L. (2019) · IEEE Transactions on Nanotechnology · doi:10.1109/tnano.2019.2904583 · Cited by 14
Conditioning Against the Pathology of Parkinson's disease.
Leak, R. K. (2018) · PubMed · Cited by 14
Zhang, L., Chen, Q., Li, P., Yuan, L., Feng, Y., Wang, J., Mao, X., & Liu, L. (2019) · Chemical Communications · doi:10.1039/c9cc06264e · Cited by 14
Wiglenda, T., Groenke, N., Hoffmann, W., Manz, C., Diez, L., Buntru, A., Brusendorf, L., Neuendorf, N., Schnoegl, S., Haenig, C., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.033 · Cited by 14
Oh, Y.-C., Jeong, Y. H., Pak, M. E., & Go, Y. (2020) · Nutrients · doi:10.3390/nu12072019 · Cited by 14
Baskakov, I. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020901 · Cited by 14
Pal, S., & SHARMA, R. R. (2021) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2021.107534 · Cited by 14
Joseph, C. R. (2021) · Diagnostics · doi:10.3390/diagnostics11101888 · Cited by 15
Macroscopic modelling of Alzheimer’s disease: difficulties and challenges
Bertsch, M., Franchi, B., Raj, A., & Tesi, M. C. (2021) · Brain Multiphysics · doi:10.1016/j.brain.2021.100040 · Cited by 14
Proteomics for comprehensive characterization of extracellular vesicles in neurodegenerative disease
Vinaiphat, A., & Sze, S. K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114149 · Cited by 14
Axonal TDP‐43 aggregates in sporadic amyotrophic lateral sclerosis
Onozato, T., Nakahara, A., Suzuki‐Kouyama, E., Hineno, A., Yasude, T., Nakamura, T., Yahikozawa, H., Watanabe, M., Kayanuma, K., Makishita, H., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12310 · Cited by 14
Raskar, T., Khavnekar, S., & Hosur, M. V. (2016) · Scientific Reports · doi:10.1038/srep32277 · Cited by 14
Effect of Mutation on an Aggregation-Prone Segment of p53: From Monomer to Dimer to Multimer
Das, A., & Makarov, D. E. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b07457 · Cited by 14
Schartner, J., Nabers, A., Budde, B., Lange, J., Hoeck, N., Wiltfang, J., Kötting, C., & Gerwert, K. B. (2017) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.7b00079 · Cited by 14
Park, J. H., Ferhan, A. R., Jackman, J. A., & Cho, N. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.04.017 · Cited by 15
Veys, L., houcke, J. V., Aerts, J., Pottelberge, S. V., Mahieu, M., Coens, A., Melki, R., Moechars, D., Muynck, L. D., & Groef, L. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.614587 · Cited by 16
Brackhan, M., Calza, G., Lundgren, K., Bascuñana, P., Brüning, T., Soliymani, R., Kumar, R., Abelein, A., Baumann, M., Lalowski, M. M., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154405 · Cited by 14
Kataoka, K., & Mochizuki, K. (2016) · Journal of Cell Science · doi:10.1242/jcs.195503 · Cited by 14
Kell, D. B., & Pretorius, E. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/054734 · Cited by 14
Neurodegenerative Disease Transmission and Transgenesis in MicePreprint
Dugger, B. N., Perl, D. P., & Carlson, G. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023549 · Cited by 14
Modeling and inference of spatio-temporal protein dynamics across brain networksPreprint
Garbarino, S., & Lorenzi, M. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1901.10545 · Cited by 14
Seo, K., Oyama, G., & Yamamoto, T. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1588027 · Cited by 13
Na,K-ATPase Acts as a Beta-Amyloid Receptor Triggering Src Kinase Activation
Petrushanko, I. Y., Tverskoi, A. M., Barykin, E. P., Petrovskaya, A. V., Strelkova, M. A., Leonova, O. G., Anashkina, A. A., Tolstova, A. P., Adzhubei, A. A., Bogdanova, A. Y., et al. (2022) · Cells · doi:10.3390/cells11172753 · Cited by 13
Rodina, N. P., Hornung, S., Sarkar, R., Suladze, S., Peters, C., Schmid, P. W. N., Niu, Z., Haslbeck, M., Büchner, J., Kapurniotu, A., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c03504 · Cited by 13
Rapid and sensitive determination of residual prion infectivity from prion-decontaminated surfaces
Simmons, S. M., Payne, V. L., Hrdlicka, J. G., Taylor, J., Larsen, P. A., Wolf, T. M., Schwabenlander, M. D., Yuan, Q., & Bartz, J. C. (2024) · mSphere · doi:10.1128/msphere.00504-24 · Cited by 14
Liu, W., Zuo, C., Li, C., Lan, H., Luo, C., Li, X., Kemp, G. J., Lui, S., Suo, X., & Gong, Q. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106174 · Cited by 13
Féger, J., & Hirsch, É. C. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.10.001 · Cited by 13
Jadiya, P., Mir, S. S., & Nazir, A. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.01.027 · Cited by 13
Pro-Inflammatory S100A9 Protein Aggregation Promoted by NCAM1 Peptide Constructs
Pansieri, J., Ostojić, L., Iashchishyn, I. A., Magzoub, M. M., Wallin, C., Wärmländer, S. K. T. S., Gräslund, A., Ngoc, M. N., Smirnovas, V., Svedružić, Ž. M., et al. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00394 · Cited by 13
Natale, C. D., Manna, S. L., Avitabile, C., Florio, D., Morelli, G., Netti, P. A., & Marasco, D. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103594 · Cited by 13
den Broeck, L. V., Sierksma, A. S. R., Hansquine, P., Thonnard, D., Callaerts‐Vegh, Z., & D’Hooge, R. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12695 · Cited by 14
Choi, Y., Kim, S.-M., Heo, Y., Lee, G., Kang, J. Y., & Yoon, D. S. (2020) · Nanotechnology · doi:10.1088/1361-6528/abba58 · Cited by 13
Dysfunctional Brain Dynamics of Parkinson's Disease and the Effect of Acute Deep Brain Stimulation
Li, Z., Ren, G., Liu, C., Wang, Q., Liang, K., Han, C., Qiao, H., Zhang, J., Wang, Q., & Meng, F. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.697909 · Cited by 13
Ziegler‐Waldkirch, S., Friesen, M., Loreth, D., Sauer, J., Kemna, S., Hilse, A., Erny, D., Helm, C., d’Errico, P., Prinz, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01686-5 · Cited by 13
Front Propagation and Arrival Times in Networks with Application to Neurodegenerative Diseases
Putra, P. S., Oliveri, H., Thompson, T., & Goriely, A. (2023) · SIAM Journal on Applied Mathematics · doi:10.1137/21m1467547 · Cited by 13
Yamada, S., Ito, H., Tanikawa, M., Ii, S., Otani, T., Wada, S., Oshima, M., Watanabe, Y., & Mase, M. (2023) · World Neurosurgery · doi:10.1016/j.wneu.2023.07.110 · Cited by 13
Kugaevskaya, E. V., Veselovsky, A., Indeykina, M., Solovyeva, N. I., Zharkova, M. S., Popov, I., Nikolaev, E., Mantsyzov, A., Makarov, A., & Kozin, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18567-5 · Cited by 14
Cytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis
Gogoleva, V. S., Атретханы, К.-С. Н., Drutskaya, M. S., Mufazalov, I. A., Kruglov, A., & Nedospasov, S. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090110 · Cited by 13
Wong, D. R., Conrad, J. C., Johnson, N. R., Ayers, J. I., Laeremans, A., Lee, J. C., Lee, J., Prusiner, S. B., Bandyopadhyay, S., Butte, A. J., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-022-00490-8 · Cited by 13
Shear-induced amyloid formation of IDPs in the brain
Trumbore, C. N. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.05.008 · Cited by 13
The Gut–Brain Axis in Parkinson's DiseasePreprint
Gao, V., Crawford, C. V., & Burré, J. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041618 · Cited by 15
Müller, H.-P., Roselli, F., Rasche, V., & Kassubek, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00734 · Cited by 12
The Glymphatic System and Sleep Dysfunction in Parkinson’s Disease
Urso, D., Gnoni, V., Rollo, E., Santoro, C., Jost, W. H., & Logroscino, G. (2025) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2025.06.008 · Cited by 12
Application of biomaterials for the detection of amyloid aggregates
Zako, T., & Maeda, M. (2014) · Biomaterials Science · doi:10.1039/c4bm00026a · Cited by 12
She, D. T., Nai, M. H., & Lim, C. T. (2024) · Med-X · doi:10.1007/s44258-024-00022-6 · Cited by 13
Ludolph, A. C., Dietrich, J., Dreyhaupt, J., Kassubek, J., Tredici, K. D., & Rosenbohm, A. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12408-y · Cited by 12
Hassan, A., Huang, Y., Mahjabina, Sudiro, O. H., Wang, X., He, J., Wei, Y., Liao, X., & Wang, G. (2024) · iMetaOmics. · doi:10.1002/imo2.33 · Cited by 13
Agouram, H., Neri, M., Angiolelli, M., Depannemaecker, D., Bahuguna, J., Schwey, A., Régis, J. M., Carron, R., Malfait, N., Eusébio, A., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01024-w · Cited by 12
Sandhof, C. A., Martin, N., Tittelmeier, J., Schlüter, A., Pezzali, M., Schöndorf, D. C., Lange, T., Reinhardt, P., Ried, J. S., Liang, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2551676 · Cited by 12
Ze Systems Generate Entropy to Forge Truth
Tkemaladze, J. (2026) · Longevity Horizon · doi:10.65649/vgrw2c93 · Cited by 12
Bigot, M., Chauveau, F., Amaz, C., Sinkus, R., Beuf, O., & Lambert, S. A. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4174 · Cited by 12
Loon, A. R., Zamudio, F., Sanneh, A., Brown, B., Smeltzer, S., Brownlow, M. L., Quadri, Z., Peters, M. M., Weeber, E. J., Nash, K. R., et al. (2021) · GeroScience · doi:10.1007/s11357-021-00408-z · Cited by 12
Yamoah, A., Yamoah, A., Tripathi, P., Guo, H., Scheive, L., Walter, P., Johnen, S., Müller, F., & Weis, J. (2023) · Cells · doi:10.3390/cells12071094 · Cited by 12
Synaptic Involvement of the Human Amygdala in Parkinson’s Disease
Villar‐Conde, S., Astillero‐Lopez, V., González-Rodríguez, M., Saiz‐Sánchez, D., Martı́nez-Marcos, A., Úbeda‐Bañón, I., & Flores‐Cuadrado, A. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100673 · Cited by 13
Upadhyay, A., Sundaria, N., Dhiman, R., Prajapati, V. K., Prasad, A., & Mishra, A. (2021) · The Neuroscientist · doi:10.1177/1073858421989582 · Cited by 12
Leger, C. S., Herbert, M., & DeSouza, J. F. X. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00364 · Cited by 12
p53, A Victim of the Prion Fashion
Billant, O., Friocourt, G., Roux, P., & Voisset, C. (2021) · Cancers · doi:10.3390/cancers13020269 · Cited by 12
Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases
Hu, C., Yan, Y., Jin, Y., Yang, J. H., Xi, Y., & Zhong, Z. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01115-9 · Cited by 11
Metadata
- Authors
- Jucker, M., & Walker, L. C.
- Affiliations
- Hertie Institute for Clinical Brain Research (DE)
- Emory University (US)
- Corresponding author
- Jucker, Mathias
- Walker, Lary C.
- Venue
- Nature
- Published
- 2013-09-04
- Volume
- 501
- Issue
- 7465
- Pages
- 45-51
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3963807
- OpenAlex
- W2034147064
- Cited by
- 1,663
- References
- 126
- Citations by year
- 2026: 82 · 2025: 113 · 2024: 114 · 2023: 111 · 2022: 119 · 2021: 161 · 2020: 140 · 2019: 153 · 2018: 131 · 2017: 166 · 2016: 147 · 2015: 119 · 2014: 101 · 2013: 6
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- National Institutes of Health (P51OD011132)
- National Institute on Aging (R21AG040589)
- National Center for Research Resources (P51RR165, P51RR000165)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- protein aggregation, seeded aggregation, neurodegenerative diseases, prion disease, Alzheimer's disease, Parkinson's disease, Creutzfeldt-Jakob disease, protein misfolding, amyloid, oligomers, proteinopathies, disease models, neurodegeneration therapy
- MeSH terms
- Alzheimer Disease, Amyloid, Animals, Humans, Prions, tau Proteins, Prion Diseases, Neurodegenerative Diseases, alpha-Synuclein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
